MedPath

Exercise Training in Chagas Cardiomyopathy

Phase 4
Completed
Conditions
Chagas Disease
Cardiomyopathy
Exercise Training
Registration Number
NCT01006473
Lead Sponsor
Federal University of Minas Gerais
Brief Summary

The benefits of exercise training in heart failure are well established. Its effects, however, have not been evaluated in Chagas cardiomyopathy (ChC). The investigators hypothesis is that the exercise training may improve functional capacity, quality of life (QoL), and reduce brain natriuretic peptide (BNP) levels in patients with ChC.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • Chronic Chagas dilated cardiomyopathy, defined by the echocardiography finding of a dilated left ventricle with moderate or severe impaired left ventricular systolic function (left ventricular ejection fraction ≤ 45%).
  • To be clinically stable for at least 3 months
  • To have sinus rhythm
  • To be under standard medical therapy use at the time.
Exclusion Criteria
  • Inability to attend regular exercise training
  • The presence of a pacemaker, associated cardiac or systemic diseases
  • Practitioners of regular physical activity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Health related quality of life12 weeks
Functional capacity12 weeks
Functional class12 weeks
BNP levels12 weeks
Secondary Outcome Measures
NameTimeMethod
Complications related to the exercise training12 weeks

Trial Locations

Locations (1)

Federal University of Minas Gerais

🇧🇷

Belo Horizonte, Minas Gerais, Brazil

Federal University of Minas Gerais
🇧🇷Belo Horizonte, Minas Gerais, Brazil

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.